Q4 2023 Aurinia Pharmaceuticals Inc Earnings Call Transcript
Greetings, and welcome to Arena Pharmaceuticals full year 2023 earnings call. (Operator Instructions) As reminder, this conference is being recorded. I would now like to turn the conference over to your host, Andrea Christopher, Head of Corporate Communications and Investor Relations for Aurinia Pharmaceuticals. Thank you. You may begin.
Thank you, operator, and thank you to everyone for joining today's call and webcast. Joining me on the call this morning are Peter Greenleaf, Aurinia's Chief Executive Officer, and Joe Miller, our Chief Financial Officer. David will review and discuss Aurinia's 2023, fourth quarter and year end financial and operational results as well as an update on our strategic review. As communicated in the company's press release issued this morning, the Company also filed its annual financial statements on Form 10 K this morning, for more information, please refer to AirMedia's filings with the US Securities and Exchange Commission and applicable
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |